Literature DB >> 6454746

T cell growth factor abrogates concanavalin A-induced suppressor cell function.

R Palacios, G Möller.   

Abstract

Concanavalin A (Con-A)-induced suppressor T cells were found to respond to T cell growth factor (TCGF) by proliferation. TCGF abrogated the suppressor activity exerted by these cells on phytohemagglutinin (PHA)- and alloantigen- induced lymphocyte proliferation and on pokeweed mitogen (PWM)-driven immunoglobulin secretion. The Con-A-activated suppressor T cells absorbed the TCGF activity, preincubation of these active suppressor cells with TCGF abolished their suppressor activity and addition of increasing numbers of Con-A-activated T cells reverted the abrogator,/ effect of TCGF. Altogether, these findings suggest that Con-A-induced suppressor T cells exert their function by decreasing the available levels of TCGF. Cyclosporin-A (CYA), which is known to inhibit the expression of receptors for TCGF on T cells, also inhibited the suppressor activity as determined in both indicator systems, namely PHA- or alloantigen-induced DNA synthesis and PWM-induced immunoglobulin synthesis. CYA made Con-A-treated T cells unresponsive to TCGF and unable to absorb the growth factor, supporting the notion that CYA inhibits the expression of TCGF receptors on T cells, a mechanism by which this drug seems to abrogate Con-A-induced suppressor T cell function.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6454746      PMCID: PMC2186149          DOI: 10.1084/jem.153.5.1360

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  7 in total

1.  Selective in vitro growth of T lymphocytes from normal human bone marrows.

Authors:  D A Morgan; F W Ruscetti; R Gallo
Journal:  Science       Date:  1976-09-10       Impact factor: 47.728

2.  The role of mitogenic lectins in T-cell triggering.

Authors:  E L Larsson; A Coutinho
Journal:  Nature       Date:  1979-07-19       Impact factor: 49.962

3.  A plaque assay for all cells secreting Ig of a given type or class.

Authors:  E Gronowicz; A Coutinho; F Melchers
Journal:  Eur J Immunol       Date:  1976-08       Impact factor: 5.532

4.  Continued growth of functional human T lymphocytes: production of human T-cell growth factor.

Authors:  G D Bonnard; K Yasaka; R D Maca
Journal:  Cell Immunol       Date:  1980-05       Impact factor: 4.868

5.  Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process.

Authors:  E L Larsson
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

6.  Autologous rosette-forming T cells as the responding cells in human autologous mixed-lymphocyte reaction.

Authors:  R Palacios; L Llorente; D Alarcón-Segovia; A Ruíz-Arguelles; E Díaz-Jouanen
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

7.  Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors.

Authors:  L Shou; S A Schwartz; R A Good
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

  7 in total
  33 in total

1.  Regulation of lymphocyte proliferation in contact sensitivity: homeostatic mechanisms and a possible explanation of antigenic competition.

Authors:  I Kimber; C J Shepherd; J A Mitchell; J L Turk; D Baker
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

2.  Neutralization of T-replacing factor by T8-positive lymphocytes: an important suppressor mechanism operating in the regulation of polyclonal B-cell activation.

Authors:  B M Jones
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

Review 3.  Mechanisms of physiologic B cell responses and B cell hyperactivity in systemic lupus erythematosus.

Authors:  R H Zubler; Y P Huang; P A Miescher
Journal:  Springer Semin Immunopathol       Date:  1986

4.  The effect of 2'deoxyguanosine on human lymphocyte responses. I. 2'deoxyguanosine enhances T lymphocyte responses.

Authors:  A C Hanglow; P M Lydyard
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

Review 5.  Exercise and the immune system. Natural killer cells, interleukins and related responses.

Authors:  R J Shephard; S Rhind; P N Shek
Journal:  Sports Med       Date:  1994-11       Impact factor: 11.136

6.  Role of individual chains of HLA-DR antigens in activation of T cells induced by alloantigens.

Authors:  R Palacios
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

7.  HLA-DR antigens induce proliferation and cytotoxicity of T cells against haptenated (TNP and FITC) self structures.

Authors:  R Palacios; G Möller; L Claesson; P A Peterson
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

8.  Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus.

Authors:  J Alcocer-Varela; D Alarcón-Segovia
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

9.  Interleukin-2 activity in chronic active liver diseases: response by T cells and in the autologous mixed lymphocyte reaction.

Authors:  K Yoshioka; S Kakumu; H Murakami; K Fukui
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

10.  In vitro generation of splenic suppressor cells by trypsin.

Authors:  F Ulrich
Journal:  Immunology       Date:  1982-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.